What is DEA form 363 used for?

DEA form 363 is specifically utilized for the new application registration of a narcotic treatment program. This form is essential for facilities that wish to obtain authorization to distribute and dispense controlled substances for the treatment of individuals with opioid use disorders. The process outlined in this form ensures that the program complies with federal regulations under the Controlled Substances Act, which is crucial for maintaining a standard of care in the treatment of addiction.

This form must be filed by any entity looking to manage a narcotic treatment program, including clinics and hospitals that provide medication-assisted therapies. The requirements set forth in this process ensure that organizations meet the necessary criteria to safely and effectively dispense narcotics as part of a comprehensive treatment plan for clients.

The other options pertain to different aspects of drug regulation and are not related to the specific registration for narcotic treatment programs, highlighting the unique purpose of form 363 in this context.